ClinicalTrials.Veeva

Menu

CEDUR - German IBD Registry

I

ImmunoRegister gUG

Status

Enrolling

Conditions

Ulcerative Colitis (UC)
Crohn Disease (CD)
Indeterminate Colitis

Study type

Observational

Funder types

Other

Identifiers

NCT07319442
HW-PV5539

Details and patient eligibility

About

The CEDUR registry systematically collects real-world data on inflammatory bowel disease (IBD) patients in Germany. The registry aims to assess quality of care, disease activity, treatment effectiveness, safety, and pharmacoeconomic aspects under routine clinical conditions.

Full description

CEDUR is a multicenter, web-based, observational registry for adult IBD patients in Germany. The registry includes Crohn's disease, ulcerative colitis, and indeterminate colitis. Data are collected prospectively from physicians and patients, covering clinical parameters, quality of life, treatment patterns, and safety outcomes. The registry supports the evaluation of care quality, cost-effectiveness, and long-term therapy outcomes under real-life conditions.

Enrollment

10,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Crohn Disease Ulcerative Colitis Indterminate Colitis

Exclusion criteria

  • Other gastrointestinal disorders than above

Trial contacts and locations

1

Loading...

Central trial contact

Stefanie Howaldt, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems